v3 Template
R

RareCyte, Inc.

Biotechnology / Life Sciences ~340 employees
Founded
--
Employees (Est.)
~340
17 leaders known
Total Funding
$20.0M
Funding Rounds
1
Last Funding
2024-06-27

About RareCyte, Inc.

RareCyte is a company focused on advancing precision biology through innovative spatial biology and liquid biopsy solutions. Their mission is to help researchers break barriers and accelerate discoveries by providing cutting-edge platforms and expert services that deliver high-resolution insights, ultra-sensitive detection, and end-to-end support for faster, more precise results.

Products & Services

Orion Spatial Biology:A platform for high-plex immunofluorescence with 20-channel multiplex imaging, flexible panel design, and high-throughput whole-slide scanning for translational research.
Orion Panels & Biomarkers:Custom and validated antibody panels for use with the Orion platform to enable spatial profiling.
CyteFinder II Imaging Instruments:Instruments for high-throughput imaging and rare cell detection with automation for blood collection to single-cell isolation.
CytePicker Retrieval Module:A module for retrieving single cells or tissue micro-regions with precision.
AccuCyte Sample Prep System:A system for preparing samples for rare cell analysis in liquid biopsy applications.
RarePlex Panel Kits:Staining panels for identification and classification of rare cells in liquid biopsy workflows.
Precision Biology Services:Custom assay development, clinical trial testing, and support for therapy selection and disease monitoring using spatial biology and liquid biopsy platforms.

Specialties

Spatial Biology Liquid Biopsy Rare Cell Detection Multiplex Immunofluorescence High-Throughput Imaging Clinical Trial Testing Custom Assay Development

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Venture Capital
T: -
FT: Venture Capital 		A: 20000000
MR: -
FA: $20M
FAN: 20000000 		D: 2024-06-27
FD: 2024-06-27 		9 investors
Venture Capital Latest
2024-06-27
$20.0M
9 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

J

Joe Victor

President & Chief Executive Officer

LinkedIn (Pro only)
R

Ron Seubert

Founder of RareCyte

LinkedIn (Pro only)
A

Andy Schwab

Founder and Partner at 5AM Ventures

LinkedIn (Pro only)
J

Jan Garfinkle

Founder of Arboretum Ventures

R

Robert Weisskoff

Partner

D

David Kabakoff

Board Member

View 14 more team members with Pro

Unlock Full Team Directory

Recent News

RareCyte, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Life Sciences
Company Size
~340 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro